Stockreport

BioRestorative Therapies Receives Patent Allowance for ThermoStem® Metabolic Disease Program

BioRestorative Therapies, Inc.  (BRTX) 
NASDAQ:AMEX Investor Relations: biorestorative.com/content/investor-relations
PDF – Further expands already formidable intellectual property estate the Company has been building for its novel ThermoStem® technology platform – MELVILLE, N.Y., Oct. [Read more]